Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The present invention utilizes the characteristic chemical property of hydrazide groups on one reactant to react with aldehyde groups or cyanate esters on the other reactant with an improved conjugate yield of at least sixty percent. More
This antibody can be used in diagnostic and research applications related to Lyme disease or other Borrelia-caused conditions. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Feb 2011 - 26 pages - $1,000
Nov 2010 - 40 pages - $500
Oct 2009 - 17 pages - $500
May 2011 - 25 pages - $500
Oct 2011 - 150 pages - $3,500
Nov 2010 - 7 pages - $500
Nov 2010 - 50 pages - $500
Nov 2011 - 7 pages - $3,835
Dec 2010 - 42 pages - $2,000
Dec 2010 - 28 pages - $500
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us